Compounds > nerolidol
Page last updated: 2024-08-20

nerolidol and Disease Models, Animal

nerolidol has been researched along with Disease Models, Animal in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's6 (46.15)24.3611
2020's6 (46.15)2.80

Authors

AuthorsStudies
Araujo, AM; Barreto, AS; de S S Barreto, R; Gonçalves, MSS; Heimfarth, L; Quintans Júnior, LJ; Santana, IR; Santos, DM; Santos, MRV; Santos, VCO; Silva, EAP; Souza, DS; Vasconcelos, CML1
Alshehri, FS; Althobaiti, YS; Irfan, HM; Niazi, ZR; Sabir, U; Ullah, A1
Hajebrahimi, Z; Parivar, K; Taheri, P; Yaghmaei, P1
Aydın, M; Çiftçi, O; Doğan, A; Hayal, TB; Özek, DA; Taşlıdere, A; Türkmen, NB; Ünüvar, S; Yaşar, Ş; Yüce, H1
Adrian, TE; Almarzooqi, S; Attoub, S; Chandran, S; Ojha, SK; Raj, V; Subramanya, SB; Venkataraman, B1
Ali, J; Haque, MM; Haque, SE; Iqubal, A; Najmi, AK; Syed, MA1
Allegretti, SM; da Silva Filho, AA; de Moraes, J; de Oliveira, RN; de Sousa, DP; Mengarda, AC; Pinto, PLS; Roquini, DB; Salvadori, MC; Silva, MP; Teixeira, FS1
Basak, N; Cetin, A; Ciftci, O; Eraslan, S; Melekoglu, R1
Cho, MH; Kim, SI; Lee, J; Lee, JH; Lee, K1
Katzin, AM; Kimura, EA; Marin Rodriguez, AA; Menchaca Vega, DS; Saito, AY; Sussmann, RAC1
Baldissera, MD; Cossetin, LF; da Rocha, MI; da Silva, AP; da Silva, AS; da Veiga, ML; Grando, TH; Monteiro, SG; Moreira, KL; Schafer, AS; Souza, CF; Stefani, LM1
Chen, F; Ding, JS; Li, D; Li, S1
Choi, IG; Han, JI; Jeung, EB; Lee, GS; Lee, SJ; Na, KJ; Park, MJ1

Other Studies

13 other study(ies) available for nerolidol and Disease Models, Animal

ArticleYear
Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:3

    Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Isoproterenol; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase

2022
Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 150

    Topics: Animals; Diet, High-Fat; Diet, Western; Disease Models, Animal; Down-Regulation; Inflammation; Insulin Resistance; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Rats; Sesquiterpenes; Tumor Necrosis Factor-alpha

2022
Neuroprotective effects of nerolidol against Alzheimer's disease in Wistar rats.
    Drug development research, 2022, Volume: 83, Issue:8

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Donepezil; Hippocampus; Humans; Neuroprotective Agents; Rats; Rats, Wistar; Solvents

2022
Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosis.
    Life sciences, 2023, Feb-15, Volume: 315

    Topics: Animals; Apoptosis; Dehydroepiandrosterone; Disease Models, Animal; Female; Humans; Inflammation; Oxidative Stress; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Sesquiterpenes

2023
Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models.
    Nutrients, 2020, Jul-08, Volume: 12, Issue:7

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antioxidants; Colon; Cytokines; Disease Models, Animal; HT29 Cells; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Macrophages; Male; Mice, Inbred C57BL; Neutrophils; NF-E2-Related Factor 2; Peroxidase; Phytochemicals; Phytotherapy; Sesquiterpenes

2020
Nerolidol protects the liver against cyclophosphamide-induced hepatic inflammation, apoptosis, and fibrosis via modulation of Nrf2, NF-κB p65, and caspase-3 signaling molecules in Swiss albino mice.
    BioFactors (Oxford, England), 2020, Volume: 46, Issue:6

    Topics: Animals; Apoptosis; Caspase 3; Cyclophosphamide; Disease Models, Animal; Fibrosis; Inflammation; Liver; Liver Diseases; Male; Mice; NF-E2-Related Factor 2; Sesquiterpenes; Signal Transduction; Transcription Factor RelA

2020
Antiparasitic activity of nerolidol in a mouse model of schistosomiasis.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:3

    Topics: Administration, Oral; Animals; Anthelmintics; Disease Models, Animal; Drug Evaluation, Preclinical; Feces; Female; Male; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Parasite Egg Count; Parasite Load; Schistosoma mansoni; Schistosomiasis mansoni; Sesquiterpenes; Treatment Outcome

2017
The beneficial effects of nerolidol and hesperidin on surgically induced endometriosis in a rat model
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:11

    Topics: Animals; Disease Models, Animal; Endometriosis; Female; Glutathione; Hesperidin; Malondialdehyde; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase; Treatment Outcome; Uterus

2018
Anti-biofilm, anti-hemolysis, and anti-virulence activities of black pepper, cananga, myrrh oils, and nerolidol against Staphylococcus aureus.
    Applied microbiology and biotechnology, 2014, Volume: 98, Issue:22

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Cananga; Disease Models, Animal; Gene Expression Profiling; Hemolysis; Oils, Volatile; Piper nigrum; Sesquiterpenes; Staphylococcus aureus; Survival Analysis; Terpenes; Virulence

2014
Antimalarial activity of the terpene nerolidol.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:6

    Topics: Administration, Inhalation; Administration, Oral; Animals; Antimalarials; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Malaria; Male; Mice, Inbred BALB C; Parasitemia; Plasmodium berghei; Sesquiterpenes; Survival Analysis; Terpenes; Treatment Outcome

2016
Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:2

    Topics: Acetylcholinesterase; Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Brain; Catalase; Central Nervous System Protozoal Infections; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; Female; GPI-Linked Proteins; Memory; Memory Disorders; Mice; Motor Activity; Nanospheres; Nootropic Agents; Oxidative Stress; Reaction Time; Reactive Oxygen Species; Sesquiterpenes; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Trypanosoma; Trypanosomiasis

2017
Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo.
    Fitoterapia, 2012, Volume: 83, Issue:5

    Topics: Administration, Cutaneous; Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Evodia; Female; Indole Alkaloids; Male; Mice; Oleic Acid; Pain; Plant Extracts; Quinazolines; Sesquiterpenes; Skin; Swine

2012
Antifungal effect of eugenol and nerolidol against Microsporum gypseum in a guinea pig model.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1

    Topics: Animals; Antifungal Agents; Cupressus; Dermatomycoses; Disease Models, Animal; Eugenol; Guinea Pigs; Hair; Male; Microbial Sensitivity Tests; Microsporum; Oils, Volatile; Sesquiterpenes; Skin; Time Factors

2007